UKRAINS'KYI VISNYK PSYKHONEVROLOHII

DOI: https://doi.org/10.36927/2079-0325-V29-is4-2021-5

Many researchers note the “neurotization” of patients with endocrine diseases, formation of psycho-emotional disorders and cognitive impairment. Prevalence of mental disorders and maladaptive forms of response to the disease reaches 70—100 % among these patients. Mental disorders and negative psychological factors complicate the course of the disease, restorative and rehabilitation processes. And it is also one of the main causes of patient’s temporary and complete disability. The data from clinical and psychopathological research indicate the presence of emotional and cognitive disorders in examined patients. Emotional disturbances are represented by anxious, depressive, astheno- hypochondriac, hysteroform variants of psychopathological symptoms. Based on the data obtained during this study, a comprehensive program of psychotherapeutic and medical psychological support for patients with type 2 diabetes has been developed.

1. Zemlianitsyna O., Polozova L., Karachentsev I., Sinaiko V., Kravchun N. (2018). Features of excretion of melatonin in urine in patients with type 2 diabetes mellitus and NAFLD with manifestations of fibrosis and its relationship with certain metabolic and immunological indicators. Georgian Medical News, 1 (274), 103-107.

2. Rodriguez-Mañas L., Laosa O., Vellas B. [et al.] Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus. Journal of Cachexia, Sarcopenia and Muscle. 2019. Vol. 10, No. 4. P. 721—733. DOI: 10.1002/jcsm.12432.

3. Mankovsky B., Zherdova N., Dalhuisen I., van den Berg E., de Bresser J., Biessels G. J. (2018). Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus. Diabetic Medicine, https://doi.org/10.1111/dme.13800.

4. Mokrii V. Ya., Ziablitsev S. V., Kryshtal M. V. (2016). Osoblyvosti formuvannia okysnoho stresu u khvorykh na tsukrovyi diabet 2-ho typu zalezhno vid tryvalosti zakhvoriuvannia ta stati. Mizhnarodnyi endokrynolohichnyi zhurnal, 5, 67-71. URI: http://nbuv.gov.ua/UJRN/Mezh_2016_5_12.

5. Hamasaki H. (2016). Daily physical activity and type 2 diabetes: a review. World Journal of Diabetes, 7 (12), 243-251, 10.4239/wjd.v7.i12.243.

6. Mykhaylov B., Mykhaylov V. (2017). Secondary depression in pationts with cardiovascular and cerebrovascular diseases. Psychiatry, psechotherapy and clinical psychology, 8 (1), 64-69. URI: http://repo.knmu.edu.ua/bitstream/123456789/16117/5/Statya_Mikhaylov_Mikhaylov.pdf.

7. Chuhunov V. V., Markova M. V., Kozhyna H. M., Kurylo V. O., Tkachenko O. V., Danilevska N. V., Haponov K. D., Zasieda Yu. I., Zahurovskyi V. M., Honcharov V. Ye., Yavorska T. P., Kryvorotko Ya. V., Kazakov V. Ye. (2020). Osoblyvosti struktury ta rozpovsiudzhenosti astenii v strukturi tsukrovoho diabetu 2-ho typu sered khvorykh riznykh sotsialnykh hrup. Problemy endokrynnoi patolohii, 2 (72), 89-94, https://doi.org/10.21856/j-PEP.2020.2.11.

8. Biessels G. J., Deary I. J., Ryan C. M. (2008). Cognition and diabetes: a lifespan perspective. The Lancet Neurology, 7 (2), 184-190. DOI: 10.1016/S1474-4422(08)70021-8.

9. Pashkovska N. V. (2018). Kohnityvni porushennia pry tsukrovomu diabeti typu 2: rol hipohlikemizuiuchoi terapii. Mizhnarodnyi endokrynolohichnyi zhurnal, 1, 76-85. URI: http://nbuv.gov.ua/UJRN/Mezh_2018_14_1_18.

10. Colberg S. R., Sigal R. J., Yardley J. E. et al. (2016). Physical activity/exercise and diabetes: a position statement of the American diabetes association. Diabetes Care, 39 (11), 2065-2079. DOI: 10.2337/dc16-1728.